CG ONCOLOGY INC (CGON:NASDAQ)
$55.53 -3.7 (-6.2468%)
Analysed CG ONCOLOGY INC (CGON:NASDAQ) News Sources
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
11-05-2026
yahoo.com
CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears
15-05-2026
marketbeat.com
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
15-05-2026
yahoo.com
Assessing CG Oncology (CGON) Valuation After Positive Phase 2 CORE-008 Bladder Cancer Data
17-05-2026
yahoo.com
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
19-05-2026
yahoo.com
CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference
21-05-2026
marketbeat.com
Sector Update: Healthcare Stocks Decline Tuesday Afternoon
26-05-2026
yahoo.com
Sector Update: Healthcare Stocks Decline Late Afternoon
26-05-2026
yahoo.com
CG Oncology to Present at Upcoming Investor Conferences in June
28-05-2026
yahoo.com
Did CG Oncology’s Leadership Consolidation Around CEO Kuan Just Shift CGON’s Commercialization Narrative?
31-05-2026
yahoo.com
What is the current price of CG ONCOLOGY INC (CGON:NASDAQ)?
The current price of CG ONCOLOGY INC (CGON:NASDAQ) is $55.53.
CG ONCOLOGY INC (CGON:NASDAQ) absolute price change since previous trading day?
The absolute price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is $-3.7.
CG ONCOLOGY INC (CGON:NASDAQ) percentage price change since previous trading day?
The percentage price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is -6.2468%.
What is the most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ) is 48 out of 100.
What is the most recent average sentiment for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent sentiment for CG ONCOLOGY INC (CGON:NASDAQ) is .
SEC-8K** Filing Available For CG ONCOLOGY INC (CGON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.